- Home
- QTRX vs SCPH Comparison
QTRX vs SCPH Comparison
Compare QTRX & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- SCPH
- Stock Information
- Founded
- QTRX 2007
- SCPH 2013
- Country
- QTRX United States
- SCPH United States
- Employees
- QTRX N/A
- SCPH N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- QTRX Industrials
- SCPH Health Care
- Exchange
- QTRX Nasdaq
- SCPH Nasdaq
- Market Cap
- QTRX 223.6M
- SCPH 173.6M
- IPO Year
- QTRX 2017
- SCPH 2017
- Fundamental
- Price
- QTRX $5.45
- SCPH $2.49
- Analyst Decision
- QTRX Buy
- SCPH Strong Buy
- Analyst Count
- QTRX 5
- SCPH 3
- Target Price
- QTRX $16.20
- SCPH $14.00
- AVG Volume (30 Days)
- QTRX 640.4K
- SCPH 251.8K
- Earning Date
- QTRX 05-12-2025
- SCPH 05-16-2025
- Dividend Yield
- QTRX N/A
- SCPH N/A
- EPS Growth
- QTRX N/A
- SCPH N/A
- EPS
- QTRX N/A
- SCPH N/A
- Revenue
- QTRX $137,421,000.00
- SCPH $36,332,000.00
- Revenue This Year
- QTRX $5.22
- SCPH $109.32
- Revenue Next Year
- QTRX $15.31
- SCPH $76.95
- P/E Ratio
- QTRX N/A
- SCPH N/A
- Revenue Growth
- QTRX 12.30
- SCPH 167.28
- 52 Week Low
- QTRX $4.67
- SCPH $1.94
- 52 Week High
- QTRX $19.18
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- QTRX 44.83
- SCPH 50.24
- Support Level
- QTRX $5.21
- SCPH $2.24
- Resistance Level
- QTRX $5.75
- SCPH $2.64
- Average True Range (ATR)
- QTRX 0.39
- SCPH 0.17
- MACD
- QTRX 0.05
- SCPH 0.02
- Stochastic Oscillator
- QTRX 35.71
- SCPH 59.62
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.